Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry.
about
Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014Role of Intravascular Ultrasound in Patients with Acute Myocardial InfarctionClinical and economic studies of eptifibatide in coronary stentingCoronary thrombus in patients undergoing primary PCI for STEMI: Prognostic significance and managementOptimal Duration of Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: Shorter or Longer?The invasive assessment of coronary atherosclerosis and stents using optical coherence tomography: a clinical updateDual antiplatelet therapy duration after the placement of a drug-eluting stent: what are the data?Acute Stent Thrombosis and Heparin Induced Thrombocytopenia in a Patient With ST-Segment Elevation Myocardial InfarctionStent thrombosis caused by metal allergy complicated by protein S deficiency and heparin-induced thrombocytopenia: a case report and review of the literature.Cardiac Evaluation and Monitoring of Patients Undergoing Noncardiac Surgery.Efficacy and safety of low-dose clopidogrel after 12-month dual antiplatelet therapy for patients having drug-eluting stent implantation.Expert position paper on the management of antiplatelet therapy in patients undergoing coronary artery bypass graft surgeryClopidogrel "resistance": where are we now?Stent thrombosis is the primary cause of ST-segment elevation myocardial infarction following coronary stent implantation: a five year follow-up of the SORT OUT II study.Role of insulin-like growth factor 1 in stent thrombosis under effective dual antiplatelet therapy.Medication adherence: WHO cares?CYP2C19 phenotype, stent thrombosis, myocardial infarction, and mortality in patients with coronary stent placement in a Chinese population.Surface modification of Ni-Ti alloys for stent application after magnetoelectropolishingClopidogrel use and early outcomes among older patients receiving a drug-eluting coronary artery stentThe hypercoagulable profile of patients with stent thrombosis.Incidence and Clinical Features of Early Stent Thrombosis in the Era of New P2y12 Inhibitors (PLATIS-2).Long-term ischaemic and bleeding outcomes after primary percutaneous coronary intervention for ST-elevation myocardial infarction in the elderlyClinical presentations, antiplatelet strategies and prognosis of patients with stent thrombosis: an observational study of 140 patients.Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction.Six-month clinical outcomes of the Tryton Side Branch Stent for the treatment of bifurcation lesions.Coronary artery disease: to cath or not to cath? When and how best to cath: those are the remaining questions.Mechanisms of stent thrombosis: insights from optical coherence tomographyRisk factors for coronary drug-eluting stent thrombosis: influence of procedural, patient, lesion, and stent related factors and dual antiplatelet therapy.Bone marrow-derived Kruppel-like factor 10 controls reendothelialization in response to arterial injury.Coronary stent thrombosis in patients with chronic renal insufficiency.Benefits of and safety concerns associated with drug-eluting coronary stents.Local drug delivery for treatment of coronary and peripheral artery disease.Prevention of the renarrowing of coronary arteries using drug-eluting stents in the perioperative period: an update.How safe and how good are drug-eluting stents?Very Late Stent Thrombosis of Sirolimus-eluting Stent 59 Months After Implantation: A First Report from The Middle-East and Review of Literature.Management of patients with recently implanted coronary stents on dual antiplatelet therapy who need to undergo major surgery.Management of antiplatelet therapy inpatients at risk for coronary StentThrombosis undergoing non-cardiac surgery.Duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent implantation: a review of the current guidelines and literature.Routine invasive versus conservative management strategies in acute coronary syndrome: time for a "hybrid" approach.Acute gastrointestinal bleeding after percutaneous coronary intervention.
P2860
Q26785321-A75ACB0D-58F3-416C-A82D-EEF0058B6A26Q26799324-29D26093-B3BF-4795-BD43-FD5271C00D64Q26830199-F7FF87B8-08B7-4832-9DE1-6659A76883EDQ26830317-7DD8025E-D851-4699-B2BF-D4FD0DAC415AQ26852812-2B3667C1-419B-4D8D-8AD9-103D8F1B5435Q30442855-FD9FB4CD-1B19-4B49-BB3E-D1F2E60E4918Q30910604-BD647659-B402-4625-8CF8-01021F6296A3Q33403975-916088E5-CAC6-48EB-B204-C8417039C257Q33424704-C8122705-9BE6-4F1E-9388-827D9B08DE20Q33583698-609EC85D-972E-4804-9D65-3EB2EA913F7DQ33586022-625AEAFE-C967-488E-91EC-C676709A1FDBQ33755419-2D139D59-946F-48BE-8C42-A027DE5F4562Q34212563-9CB3605C-03A2-405F-AE36-80EFF70FCF2FQ34542615-C1678ED6-8274-4319-AC03-72A03AE19A2CQ34613424-C43CEBEC-41D1-4984-8657-25E98BF051CBQ34627451-FC96A5F8-DE6B-438D-BFDB-B9C1A68FD713Q34649009-23D3741D-378C-42D7-B934-F8A426BF1C2FQ35304879-60212B08-0BC8-4B9F-827D-FDB714C91395Q35680854-E9EED4A4-B98F-4B65-97F7-B1883E059061Q35891856-53EECD22-6271-461B-B5D9-8168347132F8Q36054209-BA18B4AB-84A0-488C-931B-B52D3E2B8ECEQ36087392-84DF1A50-9654-485E-BF27-F0100B44E0F9Q36360516-A219EEA3-ECF0-44A2-A7E9-452B762ECB7FQ36369122-4124B358-4ACA-4F34-9642-B0E562D9CA9CQ36377265-218B362B-618B-4192-AB6C-AEA455D9B053Q36645771-FCA0EB34-E3AE-449B-AA02-89A15A18F80EQ36949011-9FAE4845-3247-4BD4-9B72-AAB2EFEAA1AAQ36995923-F58C40B5-8BF6-4BC5-8124-9EB684E7921FQ37328461-365D0D03-A146-4DC2-B4AF-E693E88AD31BQ37582058-E0B587D4-ED83-4792-9681-EB3B05188AF8Q37707419-0B867FEA-93BD-47D4-8056-2F20F4793295Q37765610-FFA823BF-31A5-4A2A-847C-011E57D6EC34Q37801291-CD03C425-F3E3-400F-8BCF-7740A4E5FC85Q37859760-23CFB4B5-26A2-4C33-8597-14DE1244268BQ37897983-C6F7DE30-8F7E-4281-8B3C-E7C6E4073549Q37912273-9B999348-D8CA-41E1-876F-F332DF0D2CE4Q37937717-A9A9AC33-0004-40AD-BE87-DCBEB95F215EQ37953153-37E8CB63-E6BE-4A74-9F55-1E1416E2650DQ37967491-6000B610-CFBA-47CB-A072-C29A44836E57Q37989162-3FC1C1D0-919B-4ACA-8159-B7978D6CE4EF
P2860
Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry.
@en
Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry.
@nl
type
label
Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry.
@en
Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry.
@nl
prefLabel
Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry.
@en
Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry.
@nl
P2093
P1476
Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry.
@en
P2093
A Carla Zomer
Antonius A Heestermans
B R Guus Brueren
Benno J Rensing
Freek W Verheugt
Jacques J Koolen
Jan-Henk E Dambrink
Jochem W van Werkum
Johannes C Kelder
Jurriën M ten Berg
P304
P356
10.1016/J.JACC.2008.12.055
P407
P577
2009-04-01T00:00:00Z